News RSS Bioethics News.

06/04/2018

Most women with a common type of early-stage breast cancer can skip chemo, a new report finds

External Link - Source: Washington Post

The cancer in question is driven by hormones, has not spread to the lymph nodes and does not contain a protein called HER2. Generally, after surgery, such patients receive endocrine therapy, such as tamoxifen, which is designed to block the cancer-spurring effects of hormones. Otis Brawley, chief medical and scientific officer of the American Cancer Society, called the trial a good example of “precision medicine” and said it would save many women from unneeded chemotherapy.

This entry was posted in Clinical Trials & Studies and tagged . Bookmark the permalink.